Brian Markison
2022
In 2022, Brian Markison earned a total compensation of $525K as President, Chief Executive Officer and Principal Financial Officer at RVL Pharmaceuticals plc, a 63% decrease compared to previous year.
Compensation breakdown
| Salary | $525,000 |
|---|---|
| Total | $525,000 |
Markison received $525K in salary, accounting for 100% of the total pay in 2022.
Rankings
In 2022, Brian Markison's compensation ranked 4,261st out of 5,736 executives tracked by ExecPay. In other words, Markison earned more than 25.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,261 out of 5,736 | 26th |
Division Manufacturing | 2,405 out of 3,125 | 23rd |
Major group Chemicals And Allied Products | 1,167 out of 1,416 | 18th |
Industry group Drugs | 1,095 out of 1,317 | 17th |
Industry Pharmaceutical Preparations | 800 out of 963 | 17th |
Source: SEC filing on April 24, 2023.
Markison's colleagues
We found three more compensation records of executives who worked with Brian Markison at RVL Pharmaceuticals plc in 2022.
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020
RVL Pharmaceuticals plc CEO Brian Markison's 2018 pay slips 10% to $1.1M
April 26, 2019